NC-100717: a versatile RGD peptide scaffold for angiogenesis imaging

Area of Science:

• Molecular Biology
• Medical Imaging
• Biochemistry

Background:

• Angiogenesis, the formation of new blood vessels, is crucial for disease progression and can be targeted for in vivo imaging.
• Endothelial cell adhesion to the extracellular matrix, mediated by integrins, is a key step in initiating angiogenesis.
• Specific integrins, such as alphavbeta3 and alphavbeta5, are upregulated during angiogenesis and are targets for molecular probes.

Purpose of the Study:

• To synthesize and characterize a novel RGD-containing peptide, NC-100717, for its potential in molecular imaging of angiogenesis.
• To evaluate the in vitro binding affinity of NC-100717 and its derived molecular probes to angiogenesis-associated integrins.

Main Methods:

• Chemical synthesis of the RGD-containing peptide NC-100717.
• Development of various molecular probes based on the NC-100717 intermediate.
• In vitro assessment of the binding affinity of these peptides and probes to target integrins.

Main Results:

• Successful synthesis of the RGD-peptide NC-100717 was achieved.
• The synthesized peptide and its derivatives demonstrated significant binding affinity to angiogenesis-related integrins.
• The study established the foundation for developing novel imaging agents targeting angiogenic processes.

Conclusions:

• The RGD-peptide NC-100717 and its derivatives show promise as molecular imaging agents for angiogenesis.
• Targeting integrins alphavbeta3 and alphavbeta5 with RGD-containing peptides is a viable strategy for in vivo disease detection.
• Further development of these probes could lead to advanced diagnostic tools for various pathologies involving neovascularization.